Treace Medical Granted Key Method Patent on its Novel Lapiplasty® System and Surgical Procedure
Treace Medical Concepts, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,622,805 which broadly covers the methods of multi-planar bunion correction embodied by the Lapiplasty® Procedure. This represents the first to issue in an aggressive pipeline of more than 20 patent applications held by the company on its Lapiplasty® System and related concepts.
According to CEO, John T. Treace, “Bunion surgical outcomes have historically been associated with high rates of recurrence and patient dissatisfaction. Studies indicate a significant contributor to deformity recurrence to be failure to correct frontal plane rotation of the metatarsal bone (the third plane of the deformity). Our Lapiplasty® Procedure was designed to realign and correct all three planes of the bunion deformity in a straightforward and reproducible manner, which we believe will demonstrate improved clinical outcomes over time.” Treace continues, “This patent issuance represents an exciting milestone for our company as it embodies the key surgical steps required to perform the breakthrough Lapiplasty® Procedure involving our novel instrumentation and implants.”
About Treace:
Treace Medical Concepts, Inc. is a medical device company specializing in the design, manufacture and marketing of device solutions for foot and ankle surgeons. Its mission is to assist foot and ankle surgeons in improving patient outcomes and reducing healthcare costs. The company is headquartered in Ponte Vedra Beach, Florida. For more information, visit www.treace.com.